Canada markets closed

Accolade, Inc. (ACCD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.25+0.26 (+2.89%)
At close: 04:00PM EDT
9.46 +0.21 (+2.27%)
After hours: 06:05PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close8.99
Open9.04
Bid9.25 x 4000
Ask9.60 x 1400
Day's Range8.90 - 9.45
52 Week Range4.61 - 55.47
Volume863,208
Avg. Volume2,139,973
Market Cap658.687M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.93
Earnings DateOct 05, 2022 - Oct 10, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.69
  • Motley Fool

    Accolade, Inc. (ACCD) Q1 2023 Earnings Call Transcript

    Good day, and thank you for standing by, and welcome to the Accolade first quarter 2023 earnings results conference call. With me on the call today are our chief executive officer, Rajeev Singh; and our chief financial officer, Steve Barnes. Shantanu Nundy, our chief medical officer, will join for the question-and-answer portion of the call.

  • Zacks

    Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates

    Accolade (ACCD) delivered earnings and revenue surprises of 45.21% and 3.80%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Accolade Announces Results for Fiscal First Quarter 2023

    Fiscal first quarter 2023 revenue of $85.5 million, a 44% increase compared to fiscal first quarter 2022 revenue of $59.5 million SEATTLE, June 30, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2022. “The healthcare consumer has never been more in need of true Personalized Healthcare. Two years into the Covid-19 pandemic, the healthcare system remains as complex and difficult to navigate as ever. Our customers,